These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 36652592

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G, Li Y, Yang M, Li G, Qian W, Xiong H, Bai T, Song J, Zhang L, Hou X.
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R, Mullin GE.
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls.
    Vasapolli R, Krikonas S, Macke L, Gravdal K, Kirste KH, Casén C, Storr M, Malfertheiner P, Schulz C.
    J Gastrointestin Liver Dis; 2024 Mar 29; 33(1):30-36. PubMed ID: 38554421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gut microbiome composition and risk factors in a large cross-sectional IBS cohort.
    Agnello M, Carroll LN, Imam N, Pino R, Palmer C, Varas I, Greene C, Hitschfeld M, Gupta S, Almonacid DE, Hoaglin MC.
    BMJ Open Gastroenterol; 2020 Mar 29; 7(1):e000345. PubMed ID: 32518661
    [Abstract] [Full Text] [Related]

  • 16. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y, Hong G, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X.
    Pharmacol Res; 2020 Sep 29; 159():104936. PubMed ID: 32470562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK.
    World J Gastroenterol; 2020 Dec 07; 26(45):7153-7172. PubMed ID: 33362374
    [Abstract] [Full Text] [Related]

  • 19. Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
    Wang T, van Dijk L, Rijnaarts I, Hermes GDA, de Roos NM, Witteman BJM, de Wit NJW, Govers C, Smidt H, Zoetendal EG.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0165322. PubMed ID: 36321894
    [Abstract] [Full Text] [Related]

  • 20. Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: Relations to subtype.
    Teige ES, Hillestad EMR, Steinsvik EK, Brønstad I, Lundervold A, Lundervold AJ, Valeur J, Hausken T, Berentsen B, Lied GA.
    Neurogastroenterol Motil; 2024 Sep 21; 36(9):e14854. PubMed ID: 38946176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.